Stock SOT SOCIETE DE THERAPEUTIQUE MAROCAINE S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Company Societe de Therapeutique Marocaine S.A.

Equities

SOT

MA0000012502

Pharmaceuticals

End-of-day quote Casablanca S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
1,010 MAD 0.00% Intraday chart for Societe de Therapeutique Marocaine S.A. -0.10% +6.20%
Apr. 19 Société de Therapeutique Marocaine S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Societe de Therapeutique Marocaine S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

Sothema (Société de Thérapeutique Marocaine) is No. 1 in Morocco of manufacturing and marketing licensed pharmaceutical products and biotechnology drugs. The group's activity is organized around 3 areas:

- drug sales: products made under license and under own names;

- importing and sales of drugs, dental products, and ophthalmic equipment;

- subcontractor fabrication of pharmaceutical products: services provided to Moroccan and foreign laboratories.

At the end of 2019, Sothema had 6 production units located in Morocco.

Sales per Business

MAD in Million2021Weight2022Weight Delta
Licensed Medicines Goods
54.8 %
1,190 57.9 % 1,262 54.8 % +6.05%
Licensed Medicines Merchandise in Morocco
39.7 %
708 34.4 % 915 39.7 % +29.23%
Licensed Medicines Goods and Services
5.5 %
158 7.7 % 126 5.5 % -20.79%

Sales per region

MAD in Million2021Weight2022Weight Delta
Africa
95.0 %
1,907 92.8 % 2,187 95.0 % +14.66%
Europe
3.3 %
109 5.3 % 75 3.3 % -31.41%
Middle East
1.0 %
-- 23 1.0 % -
America
0.7 %
2 0.1 % 17 0.7 % +858.45%

Managers

Managers TitleAgeSince
Lamia Tazi CEO
 Chief Executive Officer 47 97-10-05
Adnane Hilal DFI
 Director of Finance/CFO - -
Mehdi Zaghloul COO
 Chief Operating Officer - -
Taoufik Agoumi CTO
 Chief Tech/Sci/R&D Officer - -
Najib Bnana CTO
 Chief Tech/Sci/R&D Officer - 88-12-11
Ouadie El Euldj SAM
 Sales & Marketing - -
Mounir Haritane AUD
 Comptroller/Controller/Auditor - -
Ouhmani Youssef HRO
 Human Resources Officer - -
Rachida Haj Khalifa SAM
 Sales & Marketing - -
Naima El-Haili PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Mohamed Tazi BRD
 Director/Board Member - -
Bahia Berrada BRD
 Director/Board Member - -
Mohammed Sefrioui BRD
 Director/Board Member - 07-06-06
Karim Berrada BRD
 Director/Board Member - 06-06-28
Lamia Tazi CEO
 Chief Executive Officer 47 97-10-05
Mohammed Diouri BRD
 Director/Board Member - 09-06-03
Mohammed Jaouad Berrada BRD
 Director/Board Member - -
Mohamed Ali Tazi BRD
 Director/Board Member - -
Selma Tazi BRD
 Director/Board Member - -
El Ghali Tahiri BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 7,200,000 768,960 ( 10.68 %) 0 10.68 %

Company contact information

Sothema

Zone Industrielle Bouskoura

20180, Casablanca

+

http://www.sothema.com
address Societe de Therapeutique Marocaine S.A.(SOT)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1,010
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SOCIETE DE THERAPEUTIQUE MAROCAINE S.A. Stock Societe de Therapeutique Marocaine S.A.
+6.20% 717M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SOT Stock
  4. Company Societe de Therapeutique Marocaine S.A.